在没有经典风险因素的老年糖尿病患者中与甲福明相关的乳酸:一个病例报告
Yali Zheng1, Jia Sun1, Peng Zhang2
1Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, China.
Therapeutic advances in drug safety
|March 10, 2026
概括
甲胺是一种重要的2型糖尿病药物. 一种罕见但严重的风险是乳酸,即使在没有典型风险因素的患者中也是如此,强调需要保持警.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 甲福明是2型糖尿病 (T2DM) 的第一线治疗方法.
- 它具有成熟的安全性,但具有罕见的乳酸性酸性疾病风险.
- 风险因素通常包括/肝功能障碍,酒精和缺氧.
研究的目的:
- 在缺乏典型风险因素的患者中呈现甲胺相关的乳酸酸 (MALA) 病例.
- 强调对马拉的高度临床怀疑的重要性.
主要方法:
- 案例报告的呈现方式.
- 审查患者病史和临床表现.
主要成果:
- 一名75岁的T2DM和精神分裂症患者在没有常见风险因素的情况下发展了MALA.
- 这一案例突出了马拉的非典型表现.
结论:
- 保持MALA的高怀疑指数对于所有甲胺使用者来说至关重要.
- 早期识别和及时干预对于管理这种可能致命的并发症至关重要.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
783
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
783
Diabetes: Symptoms, Diagnosis, and Complications
2.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
302
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
302
Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
291
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
291

